Focus areas / Depression 12 Sep, 2024 Brintellix® Achieving higher rates of treatment success and satisfaction with Brintellix®1,2 12 Sep, 2024 Brintellix® Brintellix® improves overall functioning with the greatest improvement observed at 20mg1 12 Sep, 2024 Brintellix® Brintellix® pharmacokinetic profile1 12 Sep, 2024 Brintellix® Brintellix® is generally well tolerated †1 12 Sep, 2024 Brintellix® Brintellix® may be increased to 20 mg after Week 1 without compromising tolerability1 12 Sep, 2024 Brintellix® Clinical benefits of early use of Brintellix ® 20 mg 1 12 Sep, 2024 Brintellix® Brintellix® may be increased up to 20 mg without compromising patients' tolerability1 12 Sep, 2024 Brintellix® The efficacy of Brintellix® increases with increasing dose response 17 Jul, 2024 Brintellix® Differences in dose-response relationships among commonly used antidepressants 17 Jul, 2024 Brintellix® Brintellix® efficacy increases with increasing dose†1,2 09 Apr, 2024 Brintellix® Brintellix® showed clinically meaningful reductions in emotional blunting† in patients with MDD with a partial response to previous SSRIs/SNRIs‡1,3 09 Apr, 2024 Brintellix® Brintellix® improved motivation and energy in patients with MDD1 09 Apr, 2024 Brintellix® Brintellix® reduced emotional blunting in patients with MDD1 09 Apr, 2024 Brintellix® Brintellix® effectively improved overall functioning in patients with MDD with a partial response to previous SSRIs/ SNRI treatment 09 Apr, 2024 Brintellix® Increasing doses of SSRIs were associated with a linear increase in adverse events, but response rates were not 08 Feb, 2024 Brintellix® Prevalence of emotional blunting across commonly used antidepressants 07 Feb, 2024 Brintellix® Impact of emotional blunting in patients with MDD - A survey comparing the perspectives of patients and physicians 29 Sep, 2023 Brintellix® Should we switch MDD patient from SSRI to SNRI if they are experiencing sexual dysfunction? 29 Sep, 2023 Brintellix® Should we switch MDD patient from SSRI to another SSRI if they are experiencing sexual dysfunction? 29 Sep, 2023 Brintellix® Switch to vortioxetine or agomelatine if MDD patient with SSRI is experiencing sexual dysfunction? 28 Sep, 2023 Brintellix® Real-World Evidence: MDD Patients on Brintellix®(vortioxetine) showed significant remission rate with reduction of concomitant medication 28 Sep, 2023 Brintellix® Treatment options for a MDD patient like Tiffany* 28 Sep, 2023 Brintellix® Uniting Physicians and Patients - A story of Tiffany’s* 21 Jun, 2023 Brintellix® The long-term efficacy of Brintellix® (vortioxetine) in patients with major depressive disorder (MDD) [1] 21 Jun, 2023 Brintellix® The long-term efficacy of Brintellix® (vortioxetine) for working patients with major depressive disorder (MDD) [1] 21 Jun, 2023 Brintellix® Treating MDD: How Brintellix® (vortioxetine) improves a broad range of major depressive disorder (MDD) symptoms [1,2] 07 Jun, 2023 Brintellix® A randomised, double-blind, active controlled study of Brintellix® (vortioxetine) versus agomelatine in adults with Major Depressive Disorder with inadequate response to antidepressant treatment 07 Jun, 2023 Brintellix® Head-to-head study: Brintellix® (vortioxetine) vs the SNRI venlafaxine[1] 07 Jun, 2023 Brintellix® Selection of an antidepressant treatment should consider both efficacy and tolerability[1] 07 Jun, 2023 Brintellix® Patients with major depressive disorder (MDD) report a broad range of treatment goals beyond just symptom relief[1] 09 May, 2023 Brintellix® More than mood: The broad range of MDD symptoms GO TO Product Home
